CVS Lines Up Sandoz’s Adalimumab Biosimilar For US Biosimilars Subsidiary

Hyrimoz 100mg/ml To Launch Q1 2024; Business Will ‘Expand Supply Chain’

 
• By Dean Rudge
  
CVS signage on building
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products